Say Hello!
Don’t be shy.

   

News

A company based at Nottingham’s BioCity, has launched a ‘masks for the masses’ campaign selling masks for £6 (£5+VAT) each to the public and donating one for every two sold to charity. The masks are not PPE or medical grade, but do offer at the...

Excellerate Bioscience is delighted that a close relationship with Omass Therapeutics, built over 18 months, has helped contribute to their success in securing extended series A funding. During this period, Excellerate assembled a dedicated team of expert pharmacologists focussed exclusively on driving forward the Omass...

BioAscent is privileged to partner with the University of Glasgow, which is set to host a major COVID-19 testing facility to support the UK and Scottish Governments and NHS efforts against the coronavirus. The facility is part of a series of measures to increase testing in...

Amphista’s potent bifunctional small molecules augment targeted protein degradation Investors include Advent Life Sciences, the Scottish Investment Bank, the European Investment Fund and US-based BioMotiv   Glasgow, Scotland, 7 April 2020 – Amphista Therapeutics, a biopharmaceutical company creating first-in-class cancer therapeutics that harness the body’s natural processes...

Platelet Services Ltd, a contract research organisation providing pre-clinical services in platelet testing moved to BioCity Nottingham facilities in March this year. Platelet Services offers standard and customised platelet testing assays to determine the effect of compounds, or other agents, on platelet function. The company can...